The New York Times reports:
Johnson & Johnson is planning to ask U.S. federal regulators early this week to authorize a booster shot of its coronavirus vaccine, according to officials familiar with the company’s plans. The firm is the last of the three federally authorized vaccine providers to call for extra injections, amid mounting evidence that at least older adults and others in high-risk groups need more protection.
Federal officials have become increasingly worried that the more than 15 million Americans who received the Johnson & Johnson vaccine face too much risk of severe Covid-19. The Food and Drug Administration on Friday scheduled an Oct. 15 meeting of its expert advisory committee to discuss whether to grant emergency use authorization of a booster shot of the vaccine.
Read the full article.
J&J to seek FDA authorization of its booster this week https://t.co/DT6T2zIlFj
— Emily Kopp (@emilyakopp) October 4, 2021